Equity Investment |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Equity Method Investments and Joint Ventures [Abstract] | |
| Equity Investment |
Note 11 – Equity Investment
On May 21, 2025, the Company invested $100,000 in TG-17, Inc., a privately held Delaware corporation, in exchange for shares of Series CF Preferred Stock. The investment represents less than 20% of the outstanding equity of TG-17, Inc. and does not convey board representation, control rights, or any significant influence over the investee’s operating or financial policies. Accordingly, the Company accounts for the investment in accordance with ASC 321, Investments – Equity Securities, using the measurement alternative. Under this method, the investment is recorded at cost and is adjusted for any impairment or for observable price changes in orderly transactions for the identical or a similar investment of the same issuer.
As of June 30, 2025, the Company has not identified any events or changes in circumstances that would indicate impairment of the investment, nor has it observed any transactions requiring a remeasurement of its carrying value. The investment is classified as a non-current asset on the balance sheet.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|